newsfilter
← Latest News
GlobeNewswire·

Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson's Disease

BETHESDA, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (NASDAQ:GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the next generation of